supp.fit

Potassium: study protocols

104 study groups say how much Potassium participants took a day. These are the doses the studies gave. They are not a recommendation.

Potassium: what the research found →

Dose per serving from products

3,062 products in our catalogue print how much Potassium a serving holds.

Most common: 50 mg to 100 mg, 29% of 3,062 products.

Dose per servingProducts
2.5 mg or less
86
2.5 mg to 5 mg
76
5 mg to 10 mg
104
10 mg to 25 mg
311
25 mg to 50 mg
451
50 mg to 100 mg
881
100 mg to 250 mg
819
250 mg to 500 mg
261
over 500 mg
73

Dose per serving from research

59 study groups in 43 studies say how much Potassium participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 50 mmol to 100 mmol, 59% of 59 study groups.

Daily doseStudy groups
10 mmol or less
2
10 mmol to 25 mmol
8
25 mmol to 50 mmol
11
50 mmol to 100 mmol
35
100 mmol to 250 mmol
3

Commonly used together

27 of 104 study groups took Potassium with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Calcium
10
Magnesium
8
Electrolytes
5

104 study groups

Study
Therapeutic effects of potassium sodium hydrogen citrate on melamine-induced urinary calculi in China
2010 · Group 1 (low dose) · Infants and children with melamine-induced urinary calculi; average age 18.2 months
1 g26 weeks—
Therapeutic effects of potassium sodium hydrogen citrate on melamine-induced urinary calculi in China
2010 · Group 2 (high dose) · Infants and children with melamine-induced urinary calculi; average age 18.2 months
2 g26 weeks—
Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial
2024 · Inorganic nitrate · Adults aged 18 or older with non-ST-elevation acute coronary syndrome at risk of contrast-induced nephropathy, undergoing coronary angiography
12 mmol5 days319
Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study
2024 · PCSC · Adults aged 20–80 with mild-stage CKD (stages G2, G3a, or G3b)
1.5 g2 years32
Effects of magnesium and potassium supplementation on insomnia and sleep hormones in patients with diabetes mellitus
2024 · T3: Potassium · Men and women aged 19–65 with diabetes and insomnia
500 mg60 days74
[Efficacy of thyroxine and potassium iodide treatment of benign nodular thyroid lesions]
2003 · potassium iodide group · Patients with benign nodular thyroid lesions
200 mcg26 weeks59
Does a pretreatment with a dentine hypersensitivity mouth-rinse compensate the pain caused by professional mechanical plaque removal? A single-blind randomized controlled clinical trial
2021 · DPOX (test 1) · Adults attending periodontal maintenance or dental prophylaxis for primary or secondary periodontal prevention, with gingivitis or periodontitis
40 mL7 days52
An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study
1990 · cyclopenthiazide/potassium · Patients with cardiac failure requiring diuretic treatment
8.1 mmol12 weeks35
Short-term effects of combined treatment with potassium bromide and methimazole in patients with Graves' disease
2012 · combined treatment group · patients with Graves' disease
3 g30 days30
The effect of increased plasma potassium on myocardial function; a randomized POTCAST substudy
2023 · intervention group · Adults with an implantable cardioverter defibrillator, low-normal to moderately reduced left ventricular ejection fraction (35–55%), and cardiovascular disease; mean age 58 years, 81% male
2.7 g47 days25
A pilot study of potassium supplementation in the treatment of hypokalemic patients with rheumatoid arthritis: a randomized, double-blinded, placebo-controlled trial
2008 · potassium group · Adult female patients with active rheumatoid arthritis and hypokalemia; mean age 48.6 years
6 g4 weeks16
An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure
1990 · bumetanide/potassium chloride · Adults with mild congestive cardiac failure
573 mg8 weeks9
Effect of potassium phosphate supplementation on perceptual and physiological responses to maximal graded exercise
2001 · PHOS · Highly trained endurance runners; age and sex not specified
4 g2 days8
Effects of sodium and potassium supplementation on endothelial function: a fully controlled dietary intervention study
2015 · supplemental K · Untreated adults with elevated blood pressure or prehypertension; age range and sex not stated
2.8 g4 weeks—
Postprandial Vascular Effects of a High Potassium Meal in Patients with Treated Hypertension
2024 · High-potassium meal · Adults aged 18–80 with controlled, treated hypertension
2.4 g1 day—
Postprandial Vascular Effects of a High Potassium Meal in Patients with Treated Hypertension
2024 · Low-potassium meal · Adults aged 18–80 with controlled, treated hypertension
543 mg1 day—
A randomized, controlled trial of oral sulfate solution versus polyethylene glycol for bowel preparation for colonoscopy
2025 · Group A (OSS) · Men and women aged 18–70 years undergoing screening, surveillance, or diagnostic colonoscopy
3.13 g1 day324
Effects of magnesium and potassium supplementation on insomnia and sleep hormones in patients with diabetes mellitus
2024 · T4: Magnesium + potassium · Men and women aged 19–65 with diabetes and insomnia
500 mg60 days73
Effect of creatine phosphate supplementation on anaerobic working capacity and body weight after two and six days of loading in men and women
2005 · CrP · Men and women; ages and health condition not reported
4 g6 days—
Infant neurocognitive development is independent of the use of iodised salt or iodine supplements given during pregnancy
2013 · 200 μg KI/d group · Pregnant women in their first trimester
200 mcg——
Infant neurocognitive development is independent of the use of iodised salt or iodine supplements given during pregnancy
2013 · 300 μg KI/d group · Pregnant women in their first trimester
300 mcg——
Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators
1997 · active therapy · Patients with frequent ventricular arrhythmias (>720 ventricular premature beats per 24 hours); age and sex not specified
12 mmol3 weeks—
The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group
1995 · active treatment group · men and women with high-normal blood pressure and initial average diastolic blood pressure of 80–89 mm Hg
60 mmol26 weeks178
Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension
1998 · K supplementation period · Adults aged 36–77 with essential hypertension
64 mmol4 weeks55
Potassium supplementation versus bendrofluazide in mildly to moderately hypertensive Kenyans
1991 · Group A (potassium supplementation) · Black adults with confirmed but untreated hypertension
64 mmol28 weeks42
The effect of low-dose potassium supplementation on blood pressure in apparently healthy volunteers
2003 · 24 mmol slow-release KCl/d · Apparently healthy volunteers
24 mmol6 weeks30
Short-Term RCT of Increased Dietary Potassium from Potato or Potassium Gluconate: Effect on Blood Pressure, Microcirculation, and Potassium and Sodium Retention in Pre-Hypertensive-to-Hypertensive Adults
2021 · K gluconate intervention · Men and women aged 21 years and older with pre-hypertensive-to-hypertensive blood pressure who were otherwise apparently healthy
26 mmol16 days30
Randomized Trial on the Effects of Dietary Potassium on Blood Pressure and Serum Potassium Levels in Adults with Chronic Kidney Disease
2021 · higher-K diet · Adults older than 18 with stage 3 chronic kidney disease and systolic blood pressure 120–159 mmHg
100 mmol4 weeks29
Randomized Trial on the Effects of Dietary Potassium on Blood Pressure and Serum Potassium Levels in Adults with Chronic Kidney Disease
2021 · lower-K diet · Adults older than 18 with stage 3 chronic kidney disease and systolic blood pressure 120–159 mmHg
40 mmol4 weeks29
The effect of a dietary supplement of potassium chloride or potassium citrate on blood pressure in predominantly normotensive volunteers
2008 · potassium citrate (K-cit) · Predominantly young, healthy, normotensive volunteers; age and sex not specified
30 mmol6 weeks28
[Potassium citrate versus potassium chloride in essential hypertension. Effects on hemodynamic, hormonal and metabolic parameters]
1995 · potassium citrate · Adults aged 24–70 years with essential hypertension
120 mmol8 weeks25
[Potassium citrate versus potassium chloride in essential hypertension. Effects on hemodynamic, hormonal and metabolic parameters]
1995 · potassium chloride · Adults aged 24–70 years with essential hypertension
120 mmol8 weeks25
Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension
1992 · potassium chloride · Patients aged 60 years or older with hypertension
120 mmol4 days22
Potassium supplementation reduces clinic and ambulatory blood pressure in elderly hypertensive patients
1992 · potassium supplements · Elderly untreated hypertensive patients, mean age 75 years (range 66–79), with systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥95 mmHg
60 mmol4 weeks18
Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives
2005 · potassium chloride · 14 hypertensive individuals; age and sex not specified
96 mmol7 days14
Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives
2005 · potassium citrate · 14 hypertensive individuals; age and sex not specified
96 mmol7 days14
Potassium depletion exacerbates essential hypertension
1991 · Low-potassium diet · 12 patients with essential hypertension; age and sex not specified
16 mmol10 days12
Potassium depletion exacerbates essential hypertension
1991 · High-potassium diet · 12 patients with essential hypertension; age and sex not specified
96 mmol10 days12
Potassium supplementation in the treatment of idiopathic postural hypotension
1990 · potassium · Elderly patients with symptomatic idiopathic postural hypotension
60 mmol—10
Long-term potassium supplementation lowers blood pressure in elderly hypertensive subjects
1997 · 60 mmol/day potassium supplement phase · Elderly subjects with hypertension
60 mmol4 weeks8
Long-term potassium supplementation lowers blood pressure in elderly hypertensive subjects
1997 · 48 mmol daily potassium supplementation phase · Elderly subjects with hypertension
48 mmol120 days8
Effects of potassium on blood pressure in salt-sensitive and salt-resistant black adolescents
1999 · high potassium diet · Black adolescents who were salt-sensitive or salt-resistant
80 mmol3 weeks—
Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial
2001 · potassium supplementation group · Men and women aged 35–64 years with initial systolic blood pressure 130–159 mmHg and/or diastolic blood pressure 80–94 mmHg, living in a community in Beijing, China
60 mmol12 weeks—
Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study
1990 · potassium alone · Adults with mild hypertension (diastolic blood pressure less than 110 mm Hg)
60 mmol32 weeks—
Effects of sodium and potassium supplementation on blood pressure and arterial stiffness: a fully controlled dietary intervention study
2015 · supplemental potassium · Untreated (pre)hypertensive individuals; age and sex not specified
3 g4 weeks—
Effects of potassium supplementation on markers of osmoregulation and volume regulation: results of a fully controlled dietary intervention study
2016 · potassium · (Pre)hypertensive individuals; ages and sex not reported
2.8 g4 weeks—
Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial
1996 · potassium supplements · Healthy African Americans aged 27 to 65 years with systolic blood pressure of 100 to 159 mm Hg and diastolic blood pressure of 70 to 94 mm Hg
80 mmol3 weeks—
Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake
1998 · potassium · Normotensive women, mean age 39, with low habitual intake of potassium, calcium, and magnesium
40 mmol16 weeks—
Effects of creatine supplementation on body composition, strength, and sprint performance
1998 · Phosphagen HP (HP) · NCAA Division IA football players undergoing resistance/agility training; age and sex not stated
1.2 g4 weeks—
[Long term observation in effects of potassium and calcium supplementation on arterial blood pressure and sodium metabolism in adolescents with higher blood pressure]
2003 · supplementary group · Adolescents aged 18–22 with higher blood pressure
10 mmol2 years110
Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study
1990 · potassium with magnesium · Adults with mild hypertension (diastolic blood pressure less than 110 mm Hg)
60 mmol32 weeks—
Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake
1998 · all three minerals together · Normotensive women, mean age 39, with low habitual intake of potassium, calcium, and magnesium
40 mmol16 weeks—
Treatment-induced increase in total body potassium in patients at high risk of ventricular arrhythmias; a randomized POTCAST substudy
2023 · Intervention group · Adults aged 18 or older with an implantable cardioverter defibrillator and baseline plasma potassium ≤4.0 mmol/L, at high risk of malignant arrhythmias; normokalemic at baseline
2.68 g26 weeks7
Partial substitution of sodium with potassium in white bread: feasibility and bioavailability
2009 · potassium-chloride-fortified bread · Six volunteers; age, sex, and health condition not specified
22 mmol11 days6
Potassium substitution via the oral route: does its efficacy depend on the anion of the potassium salt?
1991 · potassium chloride (KCl) group · Patients with hypokalemia (serum potassium ≤3.5 mmol/L); age and sex not reported
80 mmol6 days—
Potassium substitution via the oral route: does its efficacy depend on the anion of the potassium salt?
1991 · potassium citrate/bicarbonate (K-cit/bic) group · Patients with hypokalemia (serum potassium ≤3.5 mmol/L); age and sex not reported
80 mmol6 days—
Adequacy of twice daily dosing with potassium chloride and spironolactone in thiazide treated hypertensive patients
1991 · potassium chloride · Hypertensive patients taking bendrofluazide
64 mmol6 weeks—
Effects of sodium intake and diet on racial differences in urinary potassium excretion: results from the Dietary Approaches to Stop Hypertension (DASH)-Sodium trial
2013 · Control diet · Adults with prehypertension or stage 1 hypertension
1.7 g90 days—
Effects of sodium intake and diet on racial differences in urinary potassium excretion: results from the Dietary Approaches to Stop Hypertension (DASH)-Sodium trial
2013 · DASH diet · Adults with prehypertension or stage 1 hypertension
4.1 g90 days—
Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements: A Randomized Controlled Trial
2023 · potassium citrate · 18 healthy individuals
40 mmol1 day—
Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements: A Randomized Controlled Trial
2023 · potassium chloride · 18 healthy individuals
40 mmol1 day—
Comparative Efficacy of Magnesium and Potassium Towards Cholesterol and Quality of Life in Patients With Type 2 Diabetes Mellitus: A Randomised Single-Blinded Controlled Clinical Trial
2024 · Group III (T3) · Adults aged 25–85 with type 2 diabetes mellitus; both sexes
500 mg60 days74
The Amelioration of Insulin Resistance in Salt Loading Subjects by Potassium Supplementation is Associated with a Reduction in Plasma IL-17A Levels
2017 · high-salt diet with potassium supplementation · Normotensive adults aged 29 to 65 years undergoing salt loading
4.5 g7 days45
The Effect of Salt Intake and Potassium Supplementation on Serum Gastrin Levels in Chinese Adults: A Randomized Trial
2017 · High-salt diet + potassium supplementation · Chinese adults from a rural community in northern China; normotensive or mildly hypertensive
60 mmol7 days44
Effect of sodium and potassium supplementation on vascular and endothelial function: a randomized controlled trial
2015 · high-potassium, high-sodium meal (HKHN) · Healthy, normotensive adults; mean age 37 ± 15 years; 21 women and 18 men
38 mmol1 day39
Effects of Potassium or Sodium Supplementation on Mineral Homeostasis: A Controlled Dietary Intervention Study
2020 · potassium supplementation · Adults aged 40–80 with untreated prehypertension (fasting office systolic blood pressure 130–159 mm Hg); predominantly male
2.8 g4 weeks36
Does potassium citrate administration change the type and composition of encrusted material on Double-J stent compared to primary stone?
2021 · intervention group (citrate) · Adults who underwent transurethral lithotripsy and Double-J stent insertion for ureteral stones
30 mmol50 days33
Effects of monitoring dietary biomarkers and providing vegetable juice on metabolic syndrome components in adults with an overweight or obese body mass index in Ulaanbaatar: a randomized controlled trial
2025 · monitoring + vegetable juice group · Healthy Mongolian adults aged 20 years or older with BMI ≥25 kg/m²; men and women
700 mg8 weeks32
Short-Term Supplemental Dietary Potassium from Potato and Potassium Gluconate: Effect on Calcium Retention and Urinary pH in Pre-Hypertensive-to-Hypertensive Adults
2021 · K-gluconate supplement · Men and women aged 21 years and older with systolic blood pressure >120 mmHg
1 g16 days30
Effect of Increased Potassium Intake on Adrenal Cortical and Cardiovascular Responses to Angiotensin II: A Randomized Crossover Study
2021 · Potassium treatment · Men aged 20–55 years with normotension and no stated diagnosed disease
90 mmol4 weeks25
Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans
2012 · potassium supplementation · Healthy participants; age and sex not specified
100 mmol4 weeks21
Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion
2000 · Potassium bicarbonate alone · Women aged 50 years or older
60 mmol2 weeks19
Acute effects of calcium carbonate, calcium citrate and potassium citrate on markers of calcium and bone metabolism in young women
2009 · potassium citrate · Healthy women aged 22–30 years
2.25 g1 day12
Electrocardiographic changes induced by inhaled salbutamol after treatment with bendrofluazide: effects of replacement therapy with potassium, magnesium and triamterene
1990 · bendrofluazide plus potassium · 12 normal subjects; age and sex not reported
24 mmol5 days12
Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans
2002 · hydrochlorothiazide (HCTZ; 25 mg plus 20 mmol KCl/d) · nine male hypertensive subjects
20 mmol2 weeks9
Alkaline salts to counteract bone resorption and protein wasting induced by high salt intake: results of a randomized controlled trial
2012 · KHCO3 supplementation during high NaCl intake · Healthy adult men
90 mmol10 days8
Glucocorticoid activity and metabolism with NaCl-induced low-grade metabolic acidosis and oral alkalization: results of two randomized controlled trials
2016 · High-NaCl diet supplemented with KHCO3 · Eight young, healthy, normal-weight men
90 mmol10 days8
Potassium supplementation ameliorates mineralocorticoid-induced sodium retention
1993 · KCl · Eight healthy subjects; age range and sex not reported
80 mmol10 days8
Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion
2000 · HCTZ plus potassium chloride · Healthy men and women aged 50 years or older
60 mmol2 weeks—
Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion
2000 · HCTZ plus potassium bicarbonate · Healthy men and women aged 50 years or older
60 mmol2 weeks—
Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet
2002 · high-salt diet plus potassium citrate · Postmenopausal women
90 mmol4 weeks—
Effects of potassium alkali and calcium supplementation on bone turnover in postmenopausal women
2005 · potassium citrate · postmenopausal women
4.3 g2 weeks—
Potassium bicarbonate attenuates the urinary nitrogen excretion that accompanies an increase in dietary protein and may promote calcium absorption
2009 · KHCO3 · Healthy adults aged 54–82 years
90 mmol41 days—
Pharmacokinetic Profile of Incremental Oral Doses of Dietary Nitrate in Young and Older Adults: A Crossover Randomized Clinical Trial
2022 · 200 mL KNO3 solution · Healthy, nonsmoking, nonvegetarian adults aged 18–35 and 60–75 years, without comorbidities
1 g1 day24
Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension
2006 · magnesium potassium supplementation · Patients with essential hypertension; age and sex not reported
217 mg4 weeks35
Potassium citrate supplementation results in sustained improvement in calcium balance in older men and women
2013 · potassium citrate 60 mmol/day · Healthy men and women older than 55 years, with 24-hour urine calcium at or above the study threshold; women were more than five years past menopause.
60 mmol26 weeks17
Potassium citrate supplementation results in sustained improvement in calcium balance in older men and women
2013 · potassium citrate 90 mmol/day · Healthy men and women older than 55 years, with 24-hour urine calcium at or above the study threshold; women were more than five years past menopause.
90 mmol26 weeks17
Electrocardiographic changes induced by inhaled salbutamol after treatment with bendrofluazide: effects of replacement therapy with potassium, magnesium and triamterene
1990 · bendrofluazide plus potassium plus magnesium · 12 normal subjects; age and sex not reported
24 mmol5 days12
Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults
2020 · Period I low dose (A) · Healthy adults aged 18–55 years, male or female, without major medical history or chronic treatment
102 mg/kg5 days4
Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults
2020 · Period I intermediate dose (B) · Healthy adults aged 18–55 years, male or female, without major medical history or chronic treatment
198 mg/kg5 days4
Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults
2020 · Period I high dose (C) · Healthy adults aged 18–55 years, male or female, without major medical history or chronic treatment
300 mg/kg5 days4
Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults
2020 · Period II regimen X · Healthy adults aged 18–55 years, male or female, without major medical history or chronic treatment
249 mg/kg5 days4
Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults
2020 · Period II regimen Y · Healthy adults aged 18–55 years, male or female, without major medical history or chronic treatment
249 mg/kg5 days4
Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults
2020 · Period II regimen Z · Healthy adults aged 18–55 years, male or female, without major medical history or chronic treatment
198 mg/kg5 days4
Effects of potassium alkali and calcium supplementation on bone turnover in postmenopausal women
2005 · combined treatment · postmenopausal women
4.3 g2 weeks—
Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women
2009 · potassium bicarbonate group · Men and women aged 50 and older; described as healthy older adults
67.5 mmol90 days—
Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women
2009 · potassium chloride group · Men and women aged 50 and older; described as healthy older adults
67.5 mmol90 days—
Dietary intervention with a specific micronutrient combination for the treatment of patients with cardiac arrhythmias: the impact on insulin resistance and left ventricular function
2018 · verum group · Adults aged 18–75 with cardiac arrhythmias (ventricular or supraventricular premature beats or supraventricular tachycardia); patients with cardiovascular disorders, often including hypertension or coronary artery disease
469 mg6 weeks29
Randomized Trial to Assess the Safety and Tolerability of Daily Intake of an Allulose Amino Acid-Based Hydration Beverage in Men and Women
2024 · Group 1 (one stick of product) · Healthy men and women aged 18–50 years with BMI 20–29.9 kg/m²
380 mg4 weeks10
Randomized Trial to Assess the Safety and Tolerability of Daily Intake of an Allulose Amino Acid-Based Hydration Beverage in Men and Women
2024 · Group 2 (two sticks of product) · Healthy men and women aged 18–50 years with BMI 20–29.9 kg/m²
760 mg4 weeks10
Randomized Trial to Assess the Safety and Tolerability of Daily Intake of an Allulose Amino Acid-Based Hydration Beverage in Men and Women
2024 · Group 3 (three sticks of product) · Healthy men and women aged 18–50 years with BMI 20–29.9 kg/m²
1.14 g4 weeks10
Long-term persistence of the urine calcium-lowering effect of potassium bicarbonate in postmenopausal women
2005 · KBC 30 mmol/d · Postmenopausal women
30 mmol3 years—
Long-term persistence of the urine calcium-lowering effect of potassium bicarbonate in postmenopausal women
2005 · KBC 60 mmol/d · Postmenopausal women
60 mmol3 years—
Long-term persistence of the urine calcium-lowering effect of potassium bicarbonate in postmenopausal women
2005 · KBC 90 mmol/d · Postmenopausal women
90 mmol3 years—